The left image above shows the gene FGFR1 in its natural state. The right image shows the gene when exposed to laser light, which causes the gene to activiate and deactivate. Credit: University at Buffalo.
The advancement, made possible by tiny photonic implants, could lead to new treatments for cancer, mental disorders
It seems like everything is going wireless these days. That now includes efforts to reprogram the human genome.
A new University at Buffalo-led study describes how researchers wirelessly controlled FGFR1 — a gene that plays a key role in how humans grow from embryos to adults — in lab-grown brain tissue.
The ability to manipulate the gene, the study’s authors say, could lead to new cancer treatments, and ways to prevent and treat mental disorders such as schizophrenia.
The work — spearheaded by UB researchers Josep M. Jornet, Michal K. Stachowiak, Yongho Bae and Ewa K. Stachowiak — was reported in the June edition of the Proceedings of the Institute of Electrical and Electronics Engineers.
It represents a step forward toward genetic manipulation technology that could upend the treatment of cancer, as well as the prevention and treatment of schizophrenia and other neurological illnesses. It centers on the creation of a new subfield of research the study’s authors are calling “optogenomics,” or controlling the human genome through laser light and nanotechnology.
“The potential of optogenomic interfaces is enormous,” says co-author Josep M. Jornet, PhD, associate professor in the Department of Electrical Engineering in the UB School of Engineering and Applied Sciences. “It could drastically reduce the need for medicinal drugs and other therapies for certain illnesses. It could also change how humans interact with machines.”
From “optogenetics” to “optogenomics”
For the past 20 years, scientists have been combining optics and genetics — the field of optogenetics — with a goal of employing light to control how cells interact with each other.
By doing this, one could potentially develop new treatments for diseases by correcting the miscommunications that occur between cells. While promising, this research does not directly address malfunctions in genetic blueprints that guide human growth and underlie many diseases.
The new research begins to tackle this issue because FGFR1 — it stands for Fibroblast Growth Factor Receptor 1 — holds sway over roughly 4,500 other genes, about one-fifth of the human genome, as estimated by the Human Genome Project, says study co-author Michal K. Stachowiak.
“In some respects, it’s like a boss gene,” says Stachowiak, PhD, professor in the Department of Pathology and Anatomical Sciences in the Jacobs School of Medicine and Biomedical Sciences at UB. “By controlling FGFR1, one can theoretically prevent widespread gene dysregulations in schizophrenia or in breast cancer and other types of cancer.”
Light-activated toggle switches
The research team was able to manipulate FGFR1 by creating tiny photonic brain implants. These wireless devices include nano-lasers and nano-antennas and, in the future, nano-detectors.
Researchers inserted the implants into the brain tissue, which was grown from induced pluripotent stem cells and enhanced with light-activated molecular toggle switches. They then triggered different laser lights — common blue laser, red laser and far-red laser — onto the tissue.
The interaction allowed researchers to activate and deactivate FGFR1 and its associated cellular functions — essentially hacking the gene. The work may eventually enable doctors to manipulate patients’ genomic structure, providing a way to prevent and correct gene abnormalities, says Stachowiak, who also holds an appointment in UB’s Department of Biomedical Engineering, a joint program between the Jacobs School and UB’s engineering school.
Next steps
The development is far from entering the doctor’s office or hospital, but the research team is excited about next steps, which include testing in 3D “mini-brains” and cancerous tissue.
Learn more: Researchers wirelessly hack ‘boss’ gene, a step toward reprogramming the human genome
The Latest on: Reprogramming the human genome
via Google News
The Latest on: Reprogramming the human genome
- KKR Invests In DNA Writing Tech Replay As Private Equity Pushes Into Healthcareon July 25, 2022 at 9:50 pm
Replay, a genome writing company reprogramming biology by writing and ... We’d like to use both the financial and human strengths of KKR and invest behind that,” said Kugan Sathiyanandarajah ...
- Genetic Recombination Appears to be Common in the Human Genomeon July 25, 2022 at 3:54 pm
When the genomes of parents come together to create the genome of a child, their DNA recombines; similar parts are rearranged so that a child carries secti | Genetics And Genomics ...
- DNA recombinations are widespread in human genomes and are implicated in both development and diseaseon July 25, 2022 at 1:51 pm
Scientists have discovered that recombinations of specific genomic sequences that are repeated millions of times in the genome of each of our cells are pervasively found in both normal and in disease ...
- What are genes and why are they important?on July 23, 2022 at 5:00 pm
The human genome, which is all human genes together, contains about 30,000 genes. All humans are 99.9% identical across their human genome, with only minor genetic differences leading to visible ...
- Whole Genome Amplification Market valuation is expected surpass US$ 5087.40 Million by the end of 2031on July 21, 2022 at 2:52 am
The global whole genome amplification market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a recent report released by Future Market Insights. The global market for whole ...
- We're About to Enter a New Era in Parkinson's Disease Treatmentson July 20, 2022 at 5:00 pm
We are just beginning to understand the role our genes play in the development of neurological diseases but an immense amount of progress has been made in the last 15 years since the human genome ...
- First report from the world's most ambitious sequencing projecton July 20, 2022 at 8:00 am
Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in ...
- The need for diversity in genome sequencingon July 19, 2022 at 6:36 am
A majority of the DNA that has been sequenced for research comes from donors of European ancestry. That causes a knowledge gap about the genome of people from the rest of the world.Among various ...
- Discovering the ‘Paradigm Shift’ Associated With Chemoresistance in Acute Myeloid Leukaemiaon July 8, 2022 at 10:09 am
However, none of the genes affected by SVs had a documented role in drug resistance, arguing against their involvement in reprogramming ... than 1% of CpGs in the human genome; enhanced reduced ...
- 'Jurassic World' scientists still haven't learned that just because you...on June 9, 2022 at 6:29 am
The first draft of the human genome cost an estimated US$300 million ... This in turn opened the door to reprogramming plants, microorganisms and fungi to produce pharmaceutical drugs and other ...
via Bing News